Health Canada

The purpose of this document is to provide the performance standards to be used to determine whether a remission should be granted, under the Fees in Respect of Drugs and Medical Devices Order (Order), to a person who must pay a fee under that Order.

Fees for regulatory activities related to human drugs (pharmaceutical and biological) are charged as per the Fees in Respect of Drugs and Medical Devices Order.

Sponsors will be issued an invoice for the full fee related to examining the NDS or SNDS once Health Canada has accepted the submission for review and issued the screening acceptance letter.

This document provides guidance on how fees for the review of veterinary drug submissions and applications will be administered in accordance with the Food and Drugs Act and as stipulated in the Fees in Respect of Drugs and Medical Devices Order and the Regulations Amending and Repealing Certain...